Mesenchymal stem cell was found to alleviate insulin resistance in T2DM rats by suppressing NLRP3 inflammasome-mediated inflammation and expression of IL-1β and IL-18 [32]. The gene discussed is IL18; the disease is type 2 diabetes mellitus.